| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 6 | US FAERS | |
| 2 | Nicotine | FAERS: 5 | US FAERS | |
| 3 | Erlotinib Hydrochloride | FAERS: 4 | US FAERS | |
| 4 | pazopanib | FAERS: 4 | US FAERS | |
| 5 | Asenapine | FAERS: 3 | US FAERS | |
| 6 | Lamotrigine | FAERS: 3 | OFFSIDES US FAERS | |
| 7 | Celecoxib | FAERS: 2 | US FAERS | |
| 8 | Hydralazine | FAERS: 2 | US FAERS | |
| 9 | Terbinafine | FAERS: 2 | OFFSIDES US FAERS | |
| 10 | Teriparatide | FAERS: 2 | US FAERS | |
| 11 | Tiotropium Bromide | FAERS: 2 | US FAERS | |
| 12 | Varenicline | FAERS: 2 | US FAERS | |
| 13 | cabozantinib | FAERS: 2 | US FAERS | |
| 14 | lifitegrast | FAERS: 2 | US FAERS | |
| 15 | tofacitinib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | 4-[(1R)-2-[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol | FAERS: 1 | US FAERS | |
| 17 | Acyclovir | FAERS: 1 | US FAERS | |
| 18 | Alendronate | FAERS: 1 | US FAERS | |
| 19 | Arthrotec | FAERS: 1 | US FAERS | |
| 20 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 21 | Beclomethasone | FAERS: 1 | US FAERS | |
| 22 | Budesonide | FAERS: 1 | US FAERS | |
| 23 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 24 | Capecitabine | FAERS: 1 | US FAERS | |
| 25 | Carbamazepine | FAERS: 1 | US FAERS | |
| 26 | Cinacalcet | FAERS: 1 | US FAERS | |
| 27 | Clarithromycin | FAERS: 1 | US FAERS | |
| 28 | Dextromethorphan | FAERS: 1 | US FAERS | |
| 29 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 30 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 31 | Esomeprazole | FAERS: 1 | US FAERS | |
| 32 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 33 | Fluconazole | FAERS: 1 | US FAERS | |
| 34 | Fluticasone-Salmeterol Drug Combination | FAERS: 1 | US FAERS | |
| 35 | Ibuprofen | FAERS: 1 | US FAERS | |
| 36 | Imiquimod | FAERS: 1 | US FAERS | |
| 37 | LCZ 696 | FAERS: 1 | US FAERS | |
| 38 | Lapatinib | FAERS: 1 | US FAERS | |
| 39 | Linagliptin | FAERS: 1 | US FAERS | |
| 40 | Meloxicam | FAERS: 1 | US FAERS | |
| 41 | Moxifloxacin | FAERS: 1 | US FAERS | |
| 42 | Norgestrel | FAERS: 1 | US FAERS | |
| 43 | Oseltamivir | FAERS: 1 | US FAERS | |
| 44 | PCI 32765 | FAERS: 1 | US FAERS | |
| 45 | Qsymia | FAERS: 1 | US FAERS | |
| 46 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 47 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 48 | Sertraline | FAERS: 1 | US FAERS | |
| 49 | Sertraline | FAERS: 1 | US FAERS | |
| 50 | Simcor | FAERS: 1 | US FAERS | |
| 51 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 52 | Sodium Fluoride | FAERS: 1 | US FAERS | |
| 53 | Spironolactone | FAERS: 1 | US FAERS | |
| 54 | Sunitinib | FAERS: 1 | US FAERS | |
| 55 | Terbinafine | FAERS: 1 | US FAERS | |
| 56 | Thyroxine | FAERS: 1 | US FAERS | |
| 57 | Ticagrelor | FAERS: 1 | US FAERS | |
| 58 | Valacyclovir | FAERS: 1 | US FAERS | |
| 59 | Zolpidem | FAERS: 1 | US FAERS | |
| 60 | brexpiprazole | FAERS: 1 | US FAERS | |
| 61 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 62 | pomalidomide | FAERS: 1 | US FAERS | |
| 63 | sapropterin | FAERS: 1 | US FAERS | |
| 64 | telithromycin | FAERS: 1 | US FAERS | |
| 65 | valdecoxib | FAERS: 1 | OFFSIDES US FAERS | |
| 66 | Diphenoxylate | OFFSIDES | ||
| 67 | Duotrav | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Ethylene Glycol | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Leflunomide | OFFSIDES | ||
| 70 | Mometasone Furoate | Canada Vigilance: 1 | Canada Vigilance | |
| 71 | Norethindrone | OFFSIDES | ||
| 72 | Primidone | OFFSIDES | ||
| 73 | betamethasone butyrate propionate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.